↓ Skip to main content

Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers

Overview of attention for article published in Breast Cancer Research, January 2011
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
82 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers
Published in
Breast Cancer Research, January 2011
DOI 10.1186/bcr2814
Pubmed ID
Authors

Huiling Xu, Max Yan, Jennifer Patra, Rachael Natrajan, Yuqian Yan, Sigrid Swagemakers, Jonathan M Tomaszewski, Sandra Verschoor, Ewan KA Millar, Peter van der Spek, Jorge S Reis-Filho, Robert G Ramsay, Sandra A O'Toole, Catriona M McNeil, Robert L Sutherland, Michael J McKay, Stephen B Fox

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Greece 1 1%
Italy 1 1%
Unknown 81 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 23%
Researcher 14 17%
Student > Master 9 11%
Professor > Associate Professor 7 8%
Student > Bachelor 6 7%
Other 15 18%
Unknown 13 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 28 34%
Biochemistry, Genetics and Molecular Biology 19 23%
Medicine and Dentistry 14 17%
Computer Science 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 4 5%
Unknown 13 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2023.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from Breast Cancer Research
#977
of 2,052 outputs
Outputs of similar age
#59,244
of 193,616 outputs
Outputs of similar age from Breast Cancer Research
#13
of 24 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,616 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.